November 2020 – AbolerIS Pharma raises 2,5M$ in Seed Financing from Newton Biocapital and Turenne Santé/Sham Innovation Santé.
AbolerIS Pharma foundation
November 2019 – AbolerIS Pharma is founded by Dr. Carole Guillonneau (Director of Research CNRS) and Dr. Ignacio Anegon (Director of Research INSERM) and Dr. François-Xavier Hubert (MD, PhD) in Nantes.
Carole Guillonneau will present new preclinical data at the Translational Immunology meeting on 22-23 November 2021 in Ghent, Belgium (https://www.vibconferences.be/events/translational-immunology)